基本信息
浏览量:0
职业迁徙
个人简介
Johanna Lake is a Clinician Scientist and Clinical Psychologist at the Azrieli Centre for Adult Neurodevelopmental Disabilities and Mental Health at CAMH. My clinical interests include assessment and intervention of children and youth with neurodevelopmental disabilities and mental health concerns, including individual and group based cognitive behavioural therapy and mindfulness and acceptance-based interventions. In terms of research activities, my interests fall along three lines: 1) interventions supporting caregivers; 2) the implementation of evidence-based interventions in community settings; and 3) improving medication management.
To date, a large focus of my clinical and research focus has centered on supporting families of individuals with NDDs. Parents of individuals with NDDs face significant mental health issues, including high levels of depression and anxiety. Parents who are highly stressed are less able to support their children and, when parents have better mental health, they fare better and can support their children more effectively. Despite this, the needs of parents are often neglected, with most research and supports targeted toward children. To better understand these issues, I have examined what leads to burden among caregivers of individuals with autism, and how parents perceive medication use and interactions with prescribing healthcare providers. I have also been involved in an RCT comparing a mindfulness-based parent intervention to an information group for parents of individuals with DD, and more recently, studying the delivery of web-based virtual mindfulness groups for caregivers and adults with autism across the country. Currently, I am involved in studying and facilitating Acceptance and Commitment Therapy (ACT) workshops, co-facilitated by parents alongside clinicians and researchers.
A key challenge in psychiatric rehabilitation is the implementation of interventions that have proven to be effective in funded trials in “real world” service delivery contexts. Presently, I am involved in a CIHR funded randomized controlled trial (RCT) of a transdiagnostic cognitive behavioural therapy (CBT) program targeting emotion regulation skill development in youth with NDDs. This study presents a unique opportunity to study how we translate evidence-based practice into routine clinical practice. This will involve taking a rigorous implementation science approach that considers the different stages (e.g., adoption, installation, implementation, sustainability) and levels of implementation (e.g., client/family, clinician, organization, government/policy), with the potential to inform how other evidence-based interventions can be successfully implemented across different populations in the local and international clinical community.
My research on medication use in autism has highlighted several issues related to prescriber expertise and comfort, as well as gaps in how to monitor medication use and side effects from the perspective of persons with autism. An important next step would be to take these findings and identify ways to improve and promote medication monitoring, tracking and knowledge. I am also interested in the impact of psychotropic medication use on metabolic syndromes. If we can better understand rates of these comorbid conditions among people with NDDs across the lifespan, we can identify ways to help monitor and prevent their occurrence.
To date, a large focus of my clinical and research focus has centered on supporting families of individuals with NDDs. Parents of individuals with NDDs face significant mental health issues, including high levels of depression and anxiety. Parents who are highly stressed are less able to support their children and, when parents have better mental health, they fare better and can support their children more effectively. Despite this, the needs of parents are often neglected, with most research and supports targeted toward children. To better understand these issues, I have examined what leads to burden among caregivers of individuals with autism, and how parents perceive medication use and interactions with prescribing healthcare providers. I have also been involved in an RCT comparing a mindfulness-based parent intervention to an information group for parents of individuals with DD, and more recently, studying the delivery of web-based virtual mindfulness groups for caregivers and adults with autism across the country. Currently, I am involved in studying and facilitating Acceptance and Commitment Therapy (ACT) workshops, co-facilitated by parents alongside clinicians and researchers.
A key challenge in psychiatric rehabilitation is the implementation of interventions that have proven to be effective in funded trials in “real world” service delivery contexts. Presently, I am involved in a CIHR funded randomized controlled trial (RCT) of a transdiagnostic cognitive behavioural therapy (CBT) program targeting emotion regulation skill development in youth with NDDs. This study presents a unique opportunity to study how we translate evidence-based practice into routine clinical practice. This will involve taking a rigorous implementation science approach that considers the different stages (e.g., adoption, installation, implementation, sustainability) and levels of implementation (e.g., client/family, clinician, organization, government/policy), with the potential to inform how other evidence-based interventions can be successfully implemented across different populations in the local and international clinical community.
My research on medication use in autism has highlighted several issues related to prescriber expertise and comfort, as well as gaps in how to monitor medication use and side effects from the perspective of persons with autism. An important next step would be to take these findings and identify ways to improve and promote medication monitoring, tracking and knowledge. I am also interested in the impact of psychotropic medication use on metabolic syndromes. If we can better understand rates of these comorbid conditions among people with NDDs across the lifespan, we can identify ways to help monitor and prevent their occurrence.
研究兴趣
论文共 47 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Johanna Lake,Kenneth Po-Lun Fung,Lee Steel,Carly Magnacca, Katie Cardiff,Kendra Thomson,Nicole Bobbette, Brianne Request, Sacha Bailey,Yona Lunsky
Journal of Contextual Behavioral Sciencepp.100780, (2024)
BRITISH JOURNAL OF LEARNING DISABILITIESno. 3 (2024): 512-523
BMC health services researchno. 1 (2024)
Anupam Thakur,Nicole Bobbette, Victoria Bond,Angela Gonzales,Johanna Lake, Gill Lefkowitz, Nadia Mia,Ullanda Niel, Sanjeev Sockalingam, Erica Streisslberger,Kendra Thomson, Tiziana Volpe,Yona Lunsky
BJPsych openno. 4 (2024): e130-e130
Laura St John, Gregory Borschneck, Tiziana Volpe,Anupam Thakur,Johanna Lake, Heidi Mallet, Victor Pereira,Yona Lunsky
JOURNAL OF INTELLECTUAL DISABILITIES (2024)
AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIESno. 2 (2024): 96-100
Journal of applied research in intellectual disabilities JARIDno. 6 (2022): 1360-1369
加载更多
作者统计
#Papers: 47
#Citation: 646
H-Index: 14
G-Index: 25
Sociability: 5
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn